ALL Memory Studies Migraine Studies Multiple Sclerosis Studies Parkinson’s Studies Epilepsy Studies
  • Logo Novartis

    Novartis

    Exelon Patch

    The Exelon Patch is indicated for patients with mild to severe Alzheimer’s Disease to improve nerve cells function.

    Status: Completed

    FDA Approved

     

    Details
  • biogen

    EMBARK

    Aducanumab

    Aducanumab is an anti-amyloid beta antibody made for patients with Alzheimer’s Disease.

    Status: Completed

    FDA Approved

    Details